01 8Pletaal/Pletal
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 93
2019 Revenue in Millions : 110
Growth (%) : -16
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 84
2020 Revenue in Millions : 89
Growth (%) : 1
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 82
2021 Revenue in Millions : 84
Growth (%) : -2
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 65
2022 Revenue in Millions : 82
Growth (%) : -10
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 216
2015 Revenue in Millions : 288
Growth (%) : -25
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 201
2016 Revenue in Millions : 227
Growth (%) : -11
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 128
2017 Revenue in Millions : 188
Growth (%) : -32%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 108
2018 Revenue in Millions : 132
Growth (%) : -18
LOOKING FOR A SUPPLIER?